2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells

Publication date: Available online 7 January 2021Source: Journal of Pharmacological SciencesAuthor(s): Xiaomeng Xie, Xueyin Zu, Kyle Laster, Zigang Dong, Dong Joon Kim

Source: Journal of Pharmacological Sciences - January 8, 2021 Category: Drugs & Pharmacology Source Type: research